Cancer prevention in primary care. Screening for cervical cancer, BMJ, vol.309, pp.241-249, 1994. ,
Reasons that some screening programmes fail to control cervical cancer, IARC Sci Publ, vol.76, pp.161-169, 1986. ,
Effect of population screening for carcinoma of the uterine cervix in Finland, Maturitas, vol.7, pp.3-10, 1985. ,
, Organisation of a programme for cervical cancer screening, ICRF Coordinating Committee on Cervical Screening, vol.289, pp.894-899, 1984.
Screening for cancer of the uterine cervix in Iceland 1965-1978, Acta Obstet et Gynecol Scand, vol.61, pp.199-203, 1982. ,
Assessing the evidence for organised cancer screening programmes, Eur J Cancer, vol.39, pp.1648-53, 2003. ,
Screening for cancer: state of the art and prospects for the future, World J Surg, vol.13, pp.79-83, 1989. ,
Screening for cervical cancer: when theory meets reality, BMC Cancer, vol.11, p.240, 2011. ,
Status of implementation and organization of cancer screening in the European Union member states-summary results from the second European screening report, Int J Cancer, vol.142, pp.44-56, 2018. ,
European code against Cancer 4th edition: process of reviewing the scientific evidence and revising the recommendations, Cancer Epidemiol, vol.39, pp.11-20, 2015. ,
Cancer incidence and mortality in France over the 1980-2012 period: solid tumors, Rev Epidemiolt Sante Publique, vol.62, pp.95-108, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01915012
Population-based organized cervical cancer screening pilot program in France, Eur J Canc Prev, 2017. ,
Characteristics of french women who fail to undergo regular pap smears for cervical cancer screening, BEH, vol.2, issue.3, pp.39-47, 2017. ,
Organised screening for cervical cancer in France: a cost-effectiveness assessment, BMJ Open, vol.7, p.14626, 2017. ,
, Généralisation du dépistage du cancer du col de l'utérus/Etude médico-économique/ Phase 1, appui à la décision, p.16, 2015.
, Généralisation du dépistage du cancer du col de l'utérus/Etude médico-économique/ Phase 2, appui à la décision, p.16, 2016.
Fair society, healthy lives, Public Health, vol.126, issue.1, pp.4-10, 2012. ,
DOI : 10.1093/acprof:oso/9780199931392.003.0019
A new typology of policies to tackle health inequalities and scenarios of impact based on Rose's population approach, J Epidemiol Community Health, vol.67, pp.286-91, 2013. ,
Presence, characteristics and equity of access to breast cancer screening programmes in 27 European countries in 2010 and 2014. Results from an international survey, Prev Med, vol.91, pp.250-63, 2016. ,
Towards health equity: a framework for theapplication of proportionate universalism, Int J Equity Health, vol.14, p.81, 2015. ,
, Généralisation du dépistage organisé du cancer du col de l'utérus: quel cadre éthique? Préconisations du Groupe de réflexion sur l'éthique du dépistage (GRED), collection appui à la décision, 2017.
Cervical cancer screening: an exemplar of a population screening programme and cervical cancer prevention, Cancer Prevention and Screening: Concepts, Principles and Controversies, 2018. ,
Why health equity?, Health Econ, vol.11, pp.659-66, 2002. ,
Understanding the heterogeneity of cervical cancer screening non-participants: data from a national sample of British women, Eur J Cancer, vol.80, pp.30-38, 2017. ,
To what extent is women's economic situation associated with cancer screening uptake when nationwide screening exists? A study of breast and cervical cancer screening in France in 2010, Cancer Causes Control, vol.25, pp.977-83, 2014. ,
A theory of justice, 1971. ,
Social justice, epidemiology and health inequalities, Eur J Epidemiol, vol.32, pp.537-583, 2017. ,
DOI : 10.1007/s10654-017-0286-3
URL : https://link.springer.com/content/pdf/10.1007%2Fs10654-017-0286-3.pdf
, The marmot review. London, UK: strategic review of health, Marmot Review Team. Fair society, healthy lives, 2010.
Psycho-social influences upon older women's decision to attend cervical screening: a review of current evidence, Prev Med, vol.101, pp.60-66, 2017. ,
Lesbians' attitudes and practices of cervical cancer screening: a qualitative study, BMC Womens Health, vol.14, p.153, 2014. ,
Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: update after 40-year follow-up, Gynecol Oncol, vol.146, pp.566-71, 2017. ,
Stigmatisation sociale et santé publique : les enjeux éthiques. La Santé de L'homme, vol.419, pp.9-12, 2012. ,
Stigma and the ethics of public health: not can we but should we, Soc Sci Med, vol.67, pp.463-72, 2008. ,
, Comité Consulatif National d'Ethique pour les Sciences de la Vie et de la Santé, CCNE Avis n°92, 2006.
Why France is making eight new vaccines mandatory, Vaccine, vol.36, pp.1801-1804, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01789212
Avoiding harm and supporting autonomy are under-prioritised in cancer-screening policies and practices, Eur J Cancer, vol.85, pp.1-5, 2017. ,
,
, Women's participation in breast cancer screening in France-an ethical approach, BMC Med Ethics, vol.15, p.64, 2014.
, Public health: ethical issues, Nuffield Council on bioethics, 2007.
Ethics and prevention of overweight and obesity: an inventory, Obes Rev, vol.12, pp.669-79, 2011. ,
The failure of theories of personhood, Kennedy Inst Ethics J, vol.9, pp.309-333, 1999. ,
Paternalism in public health care, Public Health Ethics, vol.1, pp.64-72, 2008. ,
A moderate pluralist approach to public health policy and ethics, Public Health Ethics, vol.2, pp.195-205, 2009. ,
Towards a normative framework for public health ethics and policy, Public Health Ethics, vol.2, pp.184-94, 2009. ,
Harm to self, 1986. ,
Principles of biomedical ethics, 1994. ,
, , 2008.
Changing the world? Reflections on the interface between social science, epidemiology and public health, J Epidemiol Community Health, vol.63, pp.867-875, 2009. ,